Skip to main content

Acute Pain Due to Trauma

3
Pipeline Programs
3
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
3
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Medical Developments International
1 program
1
MethoxyfluranePhase 3
Orion
OrionUK - Cambridge
1 program
1
MethoxyfluranePhase 31 trial
Active Trials
NCT01420159Completed300Est. Jul 2012
Orion Pharma
Orion PharmaUK - Reading
1 program
1
MethoxyfluranePhase 3

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OrionMethoxyflurane

Clinical Trials (1)

Total enrollment: 300 patients across 1 trials

NCT01420159OrionMethoxyflurane

Efficacy and Safety of Methoxyflurane (Penthrox) for the Treatment of Acute Pain in Minor Trauma

Start: Aug 2011Est. completion: Jul 2012300 patients
Phase 3Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.